We are live on ! Find out more
ACM

Argyle Capital Management Portfolio holdings

AUM $347M
1-Year Est. Return 44.33%
This Fund
S&P 500
This Quarter Est. Return
+5.2%
1 Year Est. Return
+44.33%
3 Year Est. Return
+95.77%
5 Year Est. Return
+124.66%
10 Year Est. Return
+325.03%
AUM
$309M
AUM Growth
+$12.7M
Cap. Flow
-$811K
Cap. Flow %
-0.26%
Top 10 Hldgs %
23.29%
Holding
133
New
3
Increased
7
Reduced
18
Closed
4

Top Buys

Rank Stock Value
1
OGN icon
Organon & Co
OGN
+$273K
2
PM icon
Philip Morris
PM
+$211K
3
FISV
Fiserv Inc
FISV
+$93K
4
T icon
AT&T
T
+$68.3K
5
MANT
Mantech International Corp
MANT
+$60.5K

Top Sells

Rank Stock Value
1
PRSP
Perspecta Inc. Common Stock
PRSP
+$522K
2
MRK icon
Merck
MRK
+$303K
3
SPWR
SunPower Corporation Common Stock
SPWR
+$278K
4
MUA icon
BlackRock MuniAssets Fund
MUA
+$210K
5
MO icon
Altria Group
MO
+$202K

Sector Composition

Rank Sector Weight
1 Healthcare 20.37%
2 Technology 17.64%
3 Industrials 15.32%
4 Financials 11.88%
5 Consumer Discretionary 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.45T
$13.5M 4.36%
49,830
-262
-0.5% -$66.6K
JPM icon
2
JPMorgan Chase
JPM
$935B
$6.87M 2.22%
44,162
– –
AMGN icon
3
Amgen
AMGN
$208B
$6.85M 2.21%
28,104
+200
+0.7% +$49.2K
INTC icon
4
Intel
INTC
$455B
$6.66M 2.15%
118,633
– –
MRK icon
5
Merck
MRK
$322B
$6.54M 2.11%
84,127
-4,075
-5% -$303K
UPS icon
6
United Parcel Service
UPS
$88.6B
$6.54M 2.11%
31,423
-370
-1% -$74K
LLY icon
7
Eli Lilly
LLY
$1.02T
$6.5M 2.1%
28,339
-340
-1% -$68.3K
PNC icon
8
PNC Financial Services
PNC
$99.7B
$6.37M 2.06%
33,410
– –
DE icon
9
Deere & Co
DE
$160B
$6.27M 2.03%
17,785
-5
-0% -$1.82K
PAYX icon
10
Paychex
PAYX
$41.6B
$5.97M 1.93%
55,630
– –
PFE icon
11
Pfizer
PFE
$143B
$5.95M 1.92%
151,897
– –
RTX icon
12
RTX Corp
RTX
$290B
$5.56M 1.8%
65,157
-142
-0.2% -$11.9K
MDT icon
13
Medtronic
MDT
$109B
$5.52M 1.79%
44,500
– –
BAC icon
14
Bank of America
BAC
$435B
$5.43M 1.75%
131,651
– –
JNJ icon
15
Johnson & Johnson
JNJ
$618B
$5.3M 1.71%
32,198
-233
-0.7% -$38.6K
BMY icon
16
Bristol-Myers Squibb
BMY
$133B
$5.27M 1.7%
78,924
– –
VZ icon
17
Verizon
VZ
$195B
$4.89M 1.58%
87,262
– –
PHM icon
18
Pultegroup
PHM
$24.1B
$4.82M 1.56%
88,234
– –
WAT icon
19
Waters Corp
WAT
$37B
$4.74M 1.53%
13,715
-35
-0.3% -$11.1K
KO icon
20
Coca-Cola
KO
$377B
$4.71M 1.52%
87,067
– –
CSCO icon
21
Cisco
CSCO
$457B
$4.62M 1.49%
87,078
-50
-0.1% -$2.63K
GPC icon
22
Genuine Parts
GPC
$17.1B
$4.54M 1.47%
35,910
-30
-0.1% -$3.78K
EMR icon
23
Emerson Electric
EMR
$83.9B
$4.5M 1.45%
46,749
– –
CAT icon
24
Caterpillar
CAT
$375B
$4.5M 1.45%
20,665
– –
T icon
25
AT&T
T
$159B
$4.46M 1.44%
205,183
+3,002
+1% +$68.3K
1
2 3 4 5

Similar funds

GCP
Gill Capital Partners Denver, Colorado $348M AUM 14.74% 1-Year Est. Return
AWA
Argos Wealth Advisors Sacramento, California $348M AUM
WC
Winmill & Co Rochester, New York $347M AUM 37.48% 1-Year Est. Return
LAM
LOM Asset Management Hamilton $348M AUM 29.69% 1-Year Est. Return
FFA
Fi3 Financial Advisors Indianapolis, Indiana $346M AUM 25.49% 1-Year Est. Return
VW
Vance Wealth Santa Clarita, California $346M AUM 19.74% 1-Year Est. Return
1CP
11 Capital Partners Darien, Connecticut $348M AUM 19.84% 1-Year Est. Return
NC
Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return

Argyle Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Argyle Capital Management held 133 positions worth $309M, up 4.3% from $297M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Argyle Capital Management's Q2 2021 filing shows 3 new, 7 increased, 18 reduced and 4 closed positions. Its largest new stake was Organon & Co: 8,299 shares worth $251K. The largest sale was Perspecta Inc. Common Stock, an estimated $522K.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

  • Argyle Capital Management's largest Q2 2021 buy was Organon & Co: 8,299 shares worth $251K.
  • Argyle Capital Management added most to Fiserv Inc in Q2 2021, an estimated $93K increase.
  • Argyle Capital Management's biggest Q2 2021 reduction was Merck, cutting an estimated $303K.
  • Argyle Capital Management fully exited Perspecta Inc. Common Stock in Q2 2021, selling an estimated $522K.
  • Argyle Capital Management's ten largest holdings make up 23% of its $309M portfolio in Q2 2021.
  • Argyle Capital Management opened 3 new positions and closed 4 in Q2 2021.
  • Argyle Capital Management's portfolio value rose 4.3% quarter-over-quarter to $309M.

Based on Argyle Capital Management's 13F filing for Q2 2021, filed 27 Jul 2021.